StreetInsider.com News Articles

Form SCHEDULE 13G Spectral AI, Inc. Filed by: Hudson Bay Capital Management LP

Wed, 11 Feb 2026 14:31:00 -0500

si-local-file:///var/storage/secattach/20260211/25982526.html

Form SCHEDULE 13G Spectral AI, Inc. Filed by: Hudson Bay Capital Management LP

Wed, 11 Feb 2026 14:31:00 -0500

si-local-file:///var/storage/secattach/20260211/25982526.html

Form 8-K Spectral AI, Inc. For: Feb 09

Tue, 10 Feb 2026 16:01:00 -0500

si-local-file:///var/storage/secattach/20260210/25975373.html

Form 8-K Spectral AI, Inc. For: Feb 09

Tue, 10 Feb 2026 16:01:00 -0500

si-local-file:///var/storage/secattach/20260210/25975373.html

Spectral AI appoints Vincent Capone as CEO

Tue, 10 Feb 2026 08:30:31 -0500

Spectral AI, Inc. (NASDAQ: MDAI) appointed Vincent S. Capone as Chief Executive Officer, effective February 9, 2026, the company announced. Capone previously served as the company's Chief Financial Officer and General Counsel.

The appointment comes as the Dallas-based artificial intelligence company transitions toward commercialization of its DeepView System, a burn wound assessment device. Capone has served as CFO since February 2024 and General Counsel since March 2022.

"Vince brings a unique set of leadership skills to his new role, combining a background in law, accounting, finance and operations management supported by a strong vision for the Company's future," said Dr. J. Michael

Spectral AI appoints Vincent Capone as CEO

Tue, 10 Feb 2026 08:30:31 -0500

Spectral AI Names Vincent S. Capone as Chief Executive Officer

Tue, 10 Feb 2026 08:30:00 -0500

DALLAS, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that the Company’s Board of Directors has appointed Vincent S. Capone as Chief Executive Officer of the Company, effective February 9, 2026.

The appointment of Mr. Capone, who currently serves as the Company’s Chief Financial Officer and General Counsel, comes as Spectral AI transitions towards commercialization of its proprietary, non-invasive, AI-driven burn wound assessment device – the

Spectral AI Names Vincent S. Capone as Chief Executive Officer

Tue, 10 Feb 2026 08:30:00 -0500

Form 8-K Spectral AI, Inc. For: Feb 01

Tue, 03 Feb 2026 16:02:00 -0500

si-local-file:///var/storage/secattach/20260203/25938422.html

Form 8-K Spectral AI, Inc. For: Feb 01

Tue, 03 Feb 2026 16:02:00 -0500

si-local-file:///var/storage/secattach/20260203/25938422.html

Spectral AI to Participate in National Burn Awareness Week 2026 February 1–7, 2026

Mon, 02 Feb 2026 08:30:00 -0500

DALLAS, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will join the American Burn Association (ABA) to promote practical, life-saving burn prevention strategies for workplaces of all types during this year’s National Burn Awareness Week.

In support of this annual event, Spectral AI will host a series of internal activities to engage employees, including inspiring messages from leadership, personal stories from biomedical engineers highlighting

Spectral AI to Participate in National Burn Awareness Week 2026 February 1–7, 2026

Mon, 02 Feb 2026 08:30:00 -0500

Form 8-K Spectral AI, Inc. For: Jan 05

Tue, 06 Jan 2026 16:02:00 -0500

si-local-file:///var/storage/secattach/20260106/25813078.html

Form 8-K Spectral AI, Inc. For: Jan 05

Tue, 06 Jan 2026 16:02:00 -0500

si-local-file:///var/storage/secattach/20260106/25813078.html

DeepView™ System Featured at 2025 US Burn Conferences

Wed, 19 Nov 2025 08:00:00 -0500

DALLAS, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced its prominent role at the Southern Region Burn Conference, held from October 30^th – November 2^nd in Charleston, South Carolina. The Company was featured in multiple presentations, highlighting its contributions to advancing burn care across the country.

The DeepView System was featured across several presentation topics, including initial cost savings, AI training methodology, and clinician accuracy when

DeepView™ System Featured at 2025 US Burn Conferences

Wed, 19 Nov 2025 08:00:00 -0500

The DeepView System was featured across several presentation topics, including initial cost savings, AI training methodology, and clinician accuracy when

Form 10-Q Spectral AI, Inc. For: Sep 30

Thu, 13 Nov 2025 06:01:00 -0500

si-local-file:///var/storage/secattach/20251113/25601274.html

Form 10-Q Spectral AI, Inc. For: Sep 30

Thu, 13 Nov 2025 06:01:00 -0500

si-local-file:///var/storage/secattach/20251113/25601274.html

Spectral AI (MDAI) PT Lowered to $3 at BTIG

Wed, 12 Nov 2025 04:21:50 -0500

BTIG analyst Ryan Zimmerman lowered the price target on Spectral AI (NASDAQ: MDAI) to $3.00 (from $3.50) while maintaining a Buy rating.

The analyst comments "We maintain our Buy rating but trim our PT to $3.00 (from $3.50) following 3Q25 results. MDAI reported rev. of $3.8M below BTIG ests. of $5.0M. LPS of $(0.13) was also below our est. of $(0.08). Mgmt. lowered FY25 BARDA revenue guidance to ~$18.5M (~37.6% Y/Y) from ~$21.5M as the result of timing of work on the BARDA contract as well as the government shutdown. While some of this is expected to be made up in

Spectral AI (MDAI) PT Lowered to $3 at BTIG

Wed, 12 Nov 2025 04:21:50 -0500

BTIG analyst Ryan Zimmerman lowered the price target on Spectral AI (NASDAQ: MDAI) to $3.00 (from $3.50) while maintaining a Buy rating.

Spectral AI Announces 2025 Third Quarter Financial Results

Tue, 11 Nov 2025 16:00:00 -0500

Q3 Overview

Research & Development Revenue of $3.8 Million; $15.6 Million in YTD Revenue for 2025
Strong Cash position of $10.5 Million and progress toward FDA De Novo submission

DALLAS, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the third quarter ended September 30, 2025 and provided an update on its ongoing business activities. The Company maintained a strong cash position of $10.5

Spectral AI Announces 2025 Third Quarter Financial Results

Tue, 11 Nov 2025 16:00:00 -0500

Q3 Overview

Research & Development Revenue of $3.8 Million; $15.6 Million in YTD Revenue for 2025
Strong Cash position of $10.5 Million and progress toward FDA De Novo submission

Form S-3 Spectral AI, Inc.

Thu, 30 Oct 2025 17:27:00 -0500

si-local-file:///var/storage/secattach/20251030/25532053.html

Form S-3 Spectral AI, Inc.

Thu, 30 Oct 2025 17:27:00 -0500

si-local-file:///var/storage/secattach/20251030/25532053.html

Spectral AI Schedules 2025 Third Quarter Financial Results and Conference Call

Tue, 28 Oct 2025 16:00:00 -0500

DALLAS, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the third quarter ended September 30, 2025 on Tuesday, November 11, 2025 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time that day to discuss the results.

Investors interested in participating in the live call can dial: